South Korea Oral Solid Dosage Contract Manufacturing Market Size & Outlook

The oral solid dosage contract manufacturing market in South Korea is expected to reach a projected revenue of US$ 1,798.5 million by 2030. A compound annual growth rate of 6.1% is expected of South Korea oral solid dosage contract manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,185.9
Forecast, 2030 (US$M)
$1,798.5
CAGR, 2024 - 2030
6.1%
Report Coverage
South Korea

South Korea oral solid dosage contract manufacturing market, 2018-2030 (US$M)

South

Related Markets

South Korea oral solid dosage contract manufacturing market highlights

  • The South Korea oral solid dosage contract manufacturing market generated a revenue of USD 1,185.9 million in 2023 and is expected to reach USD 1,798.5 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
  • In terms of segment, tablets was the largest revenue generating product in 2023.
  • Capsules is the most lucrative product segment registering the fastest growth during the forecast period.


Oral solid dosage contract manufacturing market data book summary

Market revenue in 2023USD 1,185.9 million
Market revenue in 2030USD 1,798.5 million
Growth rate6.1% (CAGR from 2023 to 2030)
Largest segmentTablets
Fastest growing segmentCapsules
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTablets, Capsules, Powders, Granules
Key market players worldwideCatalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc


Other key industry trends

  • In terms of revenue, South Korea accounted for 3.2% of the global oral solid dosage contract manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, India oral solid dosage contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 5,750.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Oral Solid Dosage Contract Manufacturing Market Scope

Oral solid dosage contract manufacturing market segmentation & scope
Tablets
Capsules
Powders
Granules
Others
Immediate Release
Delayed Release
Controlled Release
Large Size Companies
Medium & Small Size Companies
Others

Oral Solid Dosage Contract Manufacturing Market Companies

Name Profile # Employees HQ Website

South Korea oral solid dosage contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.


Tablets was the largest segment with a revenue share of 33.29% in 2023. Horizon Databook has segmented the South Korea oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.


South Korea, positioned as the world's tenth-largest pharmaceutical market, is identified as a significant driver for the country's prospective economic expansion. The government has actively promoted local manufacturing of medicines, increasing the number of domestic pharmaceutical companies in the market in South Korea.

This governmental support is anticipated to further propel the growth of the domestic pharmaceutical industry. Furthermore, key pharmaceutical companies are collaborating with local players to expand their market presence and strengthen their contract manufacturing capabilities in South Korea.

Reasons to subscribe to South Korea oral solid dosage contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea oral solid dosage contract manufacturing market databook

  • Our clientele includes a mix of oral solid dosage contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea oral solid dosage contract manufacturing market size, by product, 2018-2030 (US$M)

South Korea Oral Solid Dosage Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

South Korea oral solid dosage contract manufacturing market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more